The National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Program has announced $10M in funding for up to 10 new awards in FY2013.
The Phase IIB Bridge Award is designed to support the next stage of development for promising NIH-funded SBIR Phase II projects in the areas of cancer therapeutics, imaging technologies, diagnostics and prognostics, or interventional devices.
The NCI created the Bridge Award to help small businesses obtain necessary funding to bring promising cancer technologies to commercialization and ultimately improve cancer prevention, detection, and treatment for patients.
The Bridge Award funding opportunity more than triples the amount of funding available to applicants through the NCI SBIR Program and incentivizes the development of partnerships between NIH’s SBIR Phase II awardees and third-party investors and/or strategic partners.
For information on how apply to this funding announcement, please visit: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-023.html.
Applications are due: March 6, 2013.
To learn more about the SBIR Phase IIB Bridge Award, please visit: http://sbir.cancer.gov/funding/phase2bridgeaward.asp
If you are interested in applying for this opportunity and wish to use the Innovation Partnership for a Pre-Proposal Technical Review of you Phase II submission, please contact a Program Sponsor in your area, RIGHT NOW (2/11/13) in order to receive the full benefit of our program(s). The latest you can submit your electronic IPart Pre-Proposal is 2/13/13.
